Matthew Shields's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 16,195 Restricted Share Units done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries | Matthew Shields | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 16,195 | 48,587 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Matthew Shields | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 16,195 | 16,195 (0%) | 0% | - | Ordinary Shares | |
| Teva Pharmaceutical Industries | Matthew Shields | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 17.02 per share. | 03 Jun 2025 | 6,206 | 9,989 (0%) | 0% | 17.0 | 105,628 | Ordinary Shares |
| Teva Pharmaceutical Industries | Matthew Shields | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 69,182 | 69,182 | - | - | Restricted Share Units | |
| Teva Pharmaceutical Industries | Matthew Shields | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 64,782 | 64,782 | - | - | Restricted Share Units |